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ABSTRACT  
Objectives: To identify antenatal predictors of persistent pulmonary hypertension (PPH) and 
need for extracorporeal membrane oxygenation (ECMO) in fetuses with congenital 
diaphragmatic hernia (CDH). 
Material and Methods: We performed a systematic literature review of antenatal diagnostic 
tests in fetuses with isolated CDH. The target conditions were PPH within 28 days of life and 
the need for ECMO. Quality of studies was assessed with the QUADAS-2 tool. Meta-analysis 
was performed when at least three studies reported on the same test. Sensitivity analysis was 
performed according to prenatal management of CDH (tracheal occlusion versus expectant 
management). 
Results: Thirty-eight studies met the inclusion criteria. Fifteen reported on the incidence of 
PPH only, 19 on the need of ECMO only, and 4 on both outcomes.  The general quality of the 
studies was moderate; most studies were retrospective (61%) and single-centre series (92%). 
One study included only fetuses undergoing tracheal occlusion, 22 only fetuses expectantly 
managed in utero, and 15 included both populations. We could not identify antenatal 
predictors of PPH. The need for ECMO was predicted by parameters indicative of lung size: 
lung-to-head ratio (LHR, relative risk for LHR<1: 1.65; 95% confidence interval 1.27 to 2.14) 
and observed-to-expected LHR (standardized mean difference -0.70; 95% confidence interval 
-0.98 to -0.42) measured by ultrasound and observed-to-expected total lung volume 
(standardized mean difference -1.00; 95% confidence interval -1.52 to -0.48) by magnetic 
resonance. Liver herniation was also associated with an increased risk of ECMO (relative risk 
3.04; 95% confidence interval 2.23 to 4.14). These results were confirmed in a sensitivity 
analysis on studies including only expectantly managed cases. The data on vascular 
assessment for the prediction of PPH could not be pooled, as most of the parameters were 
evaluated in a single series or by a single investigator.  
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Conclusions: In fetuses with CDH, lung size and liver herniation predict the need for ECMO. 
A predictor for PPH is still lacking. Further studies aiming at diagnosing impaired vascular 
development in utero should therefore be developed. 
 
INTRODUCTION 
Congenital diaphragmatic hernia (CDH) is a life-threatening condition mainly because of 
neonatal respiratory failure due to lung hypoplasia and persistent pulmonary hypertension 
(PPH)1-4. PPH is caused by an abnormal transition of fetal to neonatal circulation5. The 
persistently elevated pulmonary vascular resistance causes right-to-left shunting of de-
oxygenated blood to the systemic circulation, resulting in arterial hypoxia6, 7 and, ultimately, 
right ventricular failure with systemic hypotension and obstructive shock8, 9. 
Unlike for other causes of neonatal respiratory failure, infants with CDH often present with 
refractory PPH resistant to inhaled nitric oxide (iNO)10, 11. When maximal medical therapy has 
failed, one may resort to extracorporeal membrane oxygenation (ECMO)12 though there is a 
lack of evidence for its efficacy13. The main concerns with ECMO are the occurrence of 
hemorrhagic and ischemic cerebral lesions resulting in later neurological and 
neurodevelopmental dysfunction14, 15. Several studies also reported an effect of ECMO on non-
neurological short term problems with feeding, growth and lung function16, 17. 
Given the severity and potential morbidity of PPH as well as the potential side-effects of 
ECMO, different research groups have searched for antenatal predictors to personalize the 
prognosis for women carrying a fetus with severe CDH. Ultrasound (US) and magnetic 
resonance imaging (MR) have both been used to assess the degree of lung hypoplasia and lung 
vascularization. Best validated are US measurement of the lung size, which permits to express 
parenchymal lung development as a function of what is expected18, 19. Conversely, much less 
attention has been paid to assessment of lung vascularization and prediction of postnatal 
cardiovascular function20, 21.   
The aim of the present study was to identify predictors of PPH and ECMO by systematic 
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review of the literature.  
METHODS 
This study was done according to the guidelines of systematic reviews Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA)22 and of the Synthesizing 
Evidence from Diagnostic Accuracy Tests (SEDATE)23. The protocol of the review was 
registered in the PROSPERO registry (CRD 42015027272). 
2.1. Search strategy 
A computerized literature search for antenatal diagnostic studies predicting occurrence of PPH 
or need for ECMO was performed in Medline via PubMed, in EMBASE, Web of Science and 
The Cochrane Central Register of Controlled Trials (CENTRAL) to identify studies published 
from inception to June 2015. The electronic search strategy included both Medical Subject 
Headings (MeSH) and keywords (free text words), and is available in the Online Supplement. 
Endnote X7 (Thomson Reuters, Carlsbad, CA, US) was used to eliminate duplicate reports. 
Reference lists and topic-related reviews were checked manually to identify further relevant 
papers. 
2.2. Selection of studies 
The studies were selected in two phases. First, titles and abstracts of the listed articles were 
screened by one reviewer (FMR) using a high sensitivity-low specificity assessment of 
relevance. Then, full texts of the selected articles were independently assessed for their 
eligibility by two investigators (FMR and MPE), according to the inclusion and exclusion 
criteria described below. Disagreements between the reviewers were resolved by discussion or 
by a third reviewer (JD). In case of overlapping studies, only the largest and most complete 
data set was included. 
2.2.1 Inclusion criteria  
Both observational and interventional studies were retrieved for further analysis. No language 
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restriction was used. Studies and/or subgroups were only included if they adequately reported 
on study population, definition of prenatal tests and on postnatal outcome (PPH and ECMO). 
In case of missing information, the corresponding authors were contacted and asked to provide 
additional data using a standardized questionnaire. 
A ‘PIRT’ (Patient-Index test-Reference test-Target condition), analogous to the ‘PICO’ 
(Patient-Intervention-Comparison-Outcome) for systematic reviews of interventional studies, 
was used to define the specific questions to be assessed24, 25.  
We only included studies on fetuses with isolated CDH (i.e. without associated anatomical 
malformations or genetic anomalies), regardless of the side of the defect and the degree of 
lung hypoplasia. Both cases that underwent fetal therapy and cases managed expectantly 
during pregnancy were included.  Studies on all relevant tests were eligible for inclusion, if an 
accurate description of the technique was provided.  
2.2.2 Exclusion criteria 
We excluded studies which were case reports, reviews, articles with no full text available and 
studies reporting only outcomes beyond 1 month of life. Studies reporting on EXIT-to-ECMO 
were excluded. Patients who underwent termination of pregnancy, fetuses with associated 
major malformations or genetic problems, and cases lacking information on postnatal outcome 
were also excluded. 
2.2.3 Target condition 
Target conditions were: (a) PPH within 28 days of life; PPH was defined by the presence of 
tricuspid regurgitation, septal bowing, and continuous or dominant right-to-left shunt through 
a patent ductus arteriosus on cardiac ultrasound26, or by a preductal–postductal saturation 
difference of 10% or higher27. Since PPH is an indication for initiating iNO or other 
vasodilators, studies reporting these type of neonatal outcomes were also included. (b) Need 
for ECMO, when applied according to consensus criteria28, 29.  
2.3. Quality appraisal 
Two reviewers (FMR, MPE) independently assessed the methodological quality of each 
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included study with the QUality Assessment of Diagnostic Accuracy Studies 2 (QUADAS 
2)30. Four domains, covering participant selection, index test, reference standard, and the flow 
of patients through the study, were rated for risk of bias (low, high, or unclear) and 
applicability concerns. Three additional items31 were considered of interest to this review and 
were also scored. These additional items refer to the definition of the positivity threshold of 
the index test, treatment given between index test and reference standard, and observer 
variation. Discrepancies between the reviewers were resolved through consensus or through a 
third reviewer (JD). Agreement between the two reviewers was analyzed with the Cohen’s 
Kappa test.  
2.4. Data extraction and analysis 
A pre-designed form was used for data extraction, which was done by two authors (FMR and 
MPE) independently. The selected studies were coded for participant characteristics, test 
characteristics and methodological aspects. Participant characteristics included study site, 
defect side, associated anomalies, degree of lung hypoplasia, prenatal and postnatal 
management. Test characteristics included the type of test, test methodology, cut-off point (if 
applicable), experience and number of the operators, gestational age at the test, type of 
reference standard, time and treatment between index test and reference standard. 
Methodological variables included study design (pro/retrospective) and duration, patient 
enrolment (consecutive or non-consecutive), sample size, inclusion/exclusion criteria, and type 
of statistical analysis.  
The results of each study were reported individually. For dichotomous variables we extracted 
the diagnostic two-by-two table (true positive, false positive, true negative, and false negative 
index test results). Continuous variables, instead, were expressed as mean ± standard deviation 
(SD) or median (interquartile range (IQR)). 
Subgroup analysis for PPH or use of vasodilators and need of ECMO was performed to test 
for differences between the two outcomes and guarantee homogeneity among the groups.  
For all variables reported on by at least three studies, we performed a meta-analysis of the 
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results. Variables were tested for statistical heterogeneity by applying the I2 test. Results were 
expressed as relative risk (RR) for categorical measures and standard difference of the mean 
(SMD) for continuous measures. A random-effect model was used. For meta-analyses 
including at least ten studies, publication bias was analyzed by visual inspection of the funnel 
plot. MedCalc software (version 15.4) was used to carry out the statistical analyses.  
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RESULTS 
3.1 Search results 
The search strategy yielded 3,533 citations. Of these, 3,442 were excluded by review of the 
title and abstract as they failed to meet the inclusion criteria. The full article was reviewed in 
91 cases of which 38 were included in the systematic review. The principal reasons for 
exclusion after full article examination were overlapping datasets (n = 17), not matching the 
review question (n = 16), and inclusion of a different study population (i.e. postnatal series, n 
= 5), next to a number of other reasons (n=15). Of the selected papers, 15 reported on the 
occurrence of PPH20, 21, 26, 32-43, 19 on the need for ECMO44-62, and 4 on both outcomes63-66 
(Figure 1). Seven corresponding authors provided relevant unpublished data32, 35, 37, 55, 63, 64, 66.  
3.2 Characteristics and quality of the included studies  
Details on the design, setting, population, index test and definition of the target condition are 
provided in Supplementary Table S1. Thirty-five studies (92%) were single-center, and 23 
(61%) were retrospective. Of the studies reporting on PPH, only 16% (3/19) restricted the 
analysis to left-sided CDH and 79% (15/19) to cases expectantly managed during pregnancy. 
Studies on the need for ECMO, instead, included a more homogeneous population: 43% 
(10/23) included only fetuses with left-sided CDH and 96% (22/23) only fetuses not 
undergoing intra-uterine therapy. Only one study reporting on PPH was limited to fetuses 
undergoing intra-uterine therapy20. 
The quality assessment of the included studies is summarized in Figure 2 and Supplementary 
Figure 1. The agreement between the two reviewers in determining the risk of bias was good, 
with Kappa ranging from 0.797 to 0.901 for the different domains. Overall, the 
methodological quality was moderate. The domains with the highest risk of bias were domain 
2, ‘Index test’, and domain 3, ‘Reference standard’. Gestational age at testing was not 
specified or broad in 21 studies (55%)21, 34-39, 44, 45, 47-52, 54, 56-58, 65, 66. In five papers (13%), the 
positivity threshold of the index test was not pre-specified50, 53, 54, 63, 66. Finally, 15 studies 
(39%) did not mention the blinding to the reference standard in the interpretation of the index 
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test21, 35-37, 40-43, 47, 48, 58, 60, 62, 65, 66.  
The proportion of studies with uncertain or high risk of bias in the ‘Reference standard’ 
domain was higher in studies reporting on PPH than in those reporting on the need of ECMO 
(89% vs 48%). The main cause of bias in the first group was the absence of a specified timing 
at the reference test for diagnosis of PPH. This was provided in the manuscript by a single 
author63, and on request by another author64.     
3.3 Proposed predictors for PPH 
Table 1 summarizes the antenatal tests for the prediction of PPH. These were mainly related to 
measurement of lung size, either with US or with MR. In detail, the most commonly proposed 
tests were the LHR, o/e LHR and o/e total lung volume (o/e TLV), reported in seven20, 26, 35, 37, 
41, 43, 63, 64, five32, 33, 37, 41, 43 and in four studies21, 26, 41, 43 respectively. Tests for direct assessment 
of the pulmonary vasculature, either anatomical or functional, have also been proposed26, 32-34, 
38-40. However, all of them have been evaluated only in single case series, or in multiple case 
series from the same author (n=2). Still, a lower o/e contralateral pulmonary artery diameter 
and a lower contralateral vascularization index consistently predicted an increased risk of 
PPH38-40. Conversely, the side of the hernia consistently did not predict the occurrence of PPH 
in both studies where it was evaluated (n=2)40, 43.  
The predictive value of liver herniation was assessed in five studies37, 43, 63, 64, 66, without 
consistency among the results from different series.  
Figure 3 shows the forest plots of the association between all predictors evaluated in at least 
three series and PPH. Summary data from individual studies included in the meta-analysis are 
provided in Table S2. PPH was not significantly associated either with a LHR <1 (RR 1.44, 
95% CI 0.42 to 4.95), or with a lower mean o/e LHR (SMD -0.06, 95% CI -1.18 to 0.07). 
However, for both tests we observed a high heterogeneity between studies. The results of the 
four studies on LHR that were not included in the meta-analysis, because reporting either odds 
ratios26, 43, or mean LHR values37, 41, were not homogeneous, with two studies demonstrating 
an association between low LHR and PPH and two with opposite results. Similarly, two 
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studies reporting on the predictive value of the o/e LHR were not included, because results 
were presented as odds ratios33, 43. In that case however, both studies did show an association 
between a lower o/e LHR and PPH. Results from studies on o/e TLV could not be pooled, 
because of high heterogeneity in the methodology for measuring o/e TLV (two studies with 
US21, 41 and two with MR26, 43), in the study population and in the reporting of statistical 
results. The results were not consistent among studies, with three studies supporting the 
correlation of a lower o/eTLV with the occurrence of PPH21, 41, 43, and one failing to show a 
significant association26.  
Finally, Figure 3C shows the forest plot for the association between liver position and PPH. 
Liver herniation did not significantly predict the occurrence of PPH (RR 1.39, 95% CI 0.821 
to 2.35). Again, there was a high heterogeneity among studies (I2 = 96.51%, p=0.0001).  
In the attempt to remove the confounding effect of intra-uterine therapy on the occurrence of 
PPH, we subsequently performed a sensitivity analysis on studies which only included patients 
managed expectantly in utero. This led to only two studies available for meta-analysis on LHR 
<135, 63 and mean o/e LHR37, 41 and to three studies evaluating the predictive value of liver 
herniation37, 63, 66. Again the occurrence of PPH did not significantly correlate with a LHR <1 
(RR 1.75, 95% CI 0.53 to 5.81), or a low o/e LHR (SMD -0.50, 95% CI -1.18 to 0.07), or with 
liver herniation (RR 1.57, 95% CI 0.96 to 2.56).  
3.4 Proposed predictors for need for ECMO 
Antenatal predictive tests for the need of ECMO are displayed in Table 2. Again, the most 
commonly proposed tests assessed lung size. The LHR was evaluated in eleven series45, 50, 51, 54-
58, 60, 63, 64, the o/eLHR in four51, 55, 56, 58 and the o/e TLV in five46, 55, 57, 58, 61 studies. Assessment 
of organs other than the lungs was also reported. Of these, the most common parameter was 
presence of  liver herniation, which was evaluated in 11 studies44, 45, 47, 50-52, 56, 57, 61, 64, 66 either 
with US (10 studies) or with MR (1 study). One study looked at the amount of liver into the 
chest as a predictor47.  
There was no consistency in any outcome of these studies in terms of predicting need for 
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ECMO. As for PPH, the side of the hernia was not associated with a difference in the 
occurrence of PPH in all the three studies where it was evaluated47, 56, 61.  
Meta-analysis was performed of studies evaluating the association of ECMO with LHR < 1 
(n=6), lower mean LHR (n=4), mean o/e LHR (n=3), mean o/e TLV (n=3) (Figure 4), being 
these the only predictors reported in at least three series. A lower lung size significantly 
predicted the need of ECMO in all cases, with a pooled RR of 1.65 (95% CI 1.27 to 2.14) for 
LHR <1 and a pooled SMD of -0.73 (95% CI -1.07 to -0.42), -0.70 (95% CI -0.98 to -0.42) 
and -1.00 (95% CI -1.52 to -0.48) for mean LHR, mean o/e LHR and mean o/e TLV 
respectively. Summary data from individual studies included in the meta-analysis are provided 
in Table S2. Low heterogeneity was observed among different studies. One paper reporting the 
predictive value of LHR and o/e LHR was not included in the meta-analysis because the 
results were expressed as odds ratio56. In that study, the two tests did not predict the need of 
ECMO. One study was not included in the meta-analysis for o/e TLV because results were 
expressed as medians, yet its conclusions were consistent with the statistical pooling of the 
other studies58.  
Similarly, a meta-analysis of ten studies reporting on the presence of liver herniation 
demonstrated that liver herniation significantly predicted the need of ECMO (RR 3.04, 95% 
CI 2.23 to 4.14). There was no heterogeneity (I2 = 0%, p=0.596), neither evidence of 
publication bias (Supplementary Figure 2). One study56 could not be pooled in the analysis, 
because of reporting only odds ratios. In that series, liver herniation was not associated with 
need for ECMO.  
The association between ECMO and an LHR <1 (RR 1.67, 95% CI 1.26 to 2.23) or the 
presence of liver herniation (RR 3.01, 95% CI 2.21 to 4.11) was confirmed even when we 
removed from the analysis one study including patients who underwent FETO64.  
  
A
cc
ep
te
d 
A
rti
cl
e
DISCUSSION 
Acquiring evidence on antenatal predictors of outcome in rare congenital anomalies is a major 
challenge, first because of the low incidence of these conditions, and second because of a lack 
of standardization for testing and of adequately sized prospective studies. Additionally, there is 
lack of standardized time points for measurement, inconsistencies in perinatal management 
protocol, prenatal intervention, and effect of gestational age at delivery and postnatal events on 
the outcomes studied.  
 
Prenatal prediction studies in CDH have been significantly boosted by the introduction of fetal 
therapy and when the condition is isolated, lung size and liver position can be used to predict 
lethal pulmonary hypoplasia to a certain extent67, 68. To further improve prediction, we here 
looked at other determinants of outcome: PPH is commonly associated with poor long term 
outcome14, 69. The need and relevance of assessing the risk for PPH prior to birth is 
acknowledged by experts13. Alongside PPH, severe ventilatory insufficiency may also lead to 
the use of ECMO70 , which may in its own be an independent predictor of outcome due to the 
complications associated with this therapy14.  
 
Overall, we identified more than fifteen claimed predictors for each of these adverse 
outcomes. Most are direct or indirect measurements of lung size21, 26, 32, 33, 35, 37, 40, 41, 43, 45, 46, 48-51, 
53-58, 60-66, either using MR or US. Other indicators concern herniation of abdominal organs into 
the thorax, among which the most commonly evaluated was liver herniation36, 40, 43-45, 47, 50, 51, 56, 
57, 61, 64, 66, 71, either categorized as absent or present or quantified. For the prediction of PPH, 
attempts to directly assess pulmonary vasculature include measurements of the pulmonary 
arterial diameters26, 39, 40, studies of flow in the pulmonary arteries33, 34, 72 –with or without 
hyperoxygenation- or more complex three-dimensional power Doppler techniques38, 40, 41. 
These indicators however were only assessed by a single author or reported inconsistent 
findings73. For most of these variables, a normative study on healthy fetuses, enabling a more 
comprehensive interpretation of the results, is also lacking. Ultimately, the vast majority of the 
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studies reporting on PPH presented an uncertain or high risk of bias mainly due to an 
unspecified or broad range of gestational age at execution.  
We were only able to perform a meta-analysis of studies reporting on lung size and liver 
herniation. Surprisingly, the results on the two target conditions were conflicting. We found a 
three-fold increase in the risk for ECMO when the liver was herniated and a 1.7 fold increase 
when the LHR was <1.0. However, smaller lung size or liver herniation were not associated 
with an increased risk of PPH. There are many possible explanations for this. First, the number 
of studies included in the meta-analyses for PPH was much lower than those for ECMO, thus 
reducing the statistical power to detect a difference. Second, we observed significant 
heterogeneity among studies reporting on PPH, perhaps due to a more heterogeneous study 
population: unlike studies on ECMO, most studies (>80%) concerning PPH included left- and 
right-sided CDH cases, with some (20%) including both fetuses managed expectantly and by 
invasive fetal surgery. Finally, a lack of consistency in the timing of post-natal assessment of 
PPH even further complicated the analysis: only two studies reported the exact timing of 
echocardiographic evaluation of PPH. Standardization of the time point of assessment for PPH 
is important as its incidence decreases during the first weeks of life74. Later evaluations may 
exclude neonates with severe PPH who died in the early postnatal periods introducing 
ascertainment bias. Similarly, some studies report only on PPH refractory to first line therapy 
(iNO), thus cases resolved after initial therapy were not included hence PPH incidence being 
underestimated. Finally, resorting to ECMO may be influenced by other aspects of post-natal 
management, including ventilation modality or access to alternative treatments for PPH, and 
ECMO can be started for respiratory failure other than PPH75.   
 
The strengths of our study include a very sensitive search strategy and a rigorous study 
selection and quality assessment in line with the most recent guidelines for conduct and 
reporting of systematic reviews. This is the first study to investigate the prediction value of 
prenatally relevant morbidity indicators for PPH.  Our review nevertheless also has 
limitations. Although a substantial number of studies was included, many predictors were only 
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assessed by a single research group, thereby limiting our ability to pool data and limiting the 
statistical power in detecting heterogeneity and publication bias across studies. Furthermore, 
adjustments for potential confounding factors, like side of the hernia and intrauterine 
management, were not consistent across studies. To increase the homogeneity among study 
populations we performed a sub-analysis of studies only including patients managed 
expectantly in utero, confirming the results previously obtained. However, this further reduced 
the number of pooled studies, especially in the analysis of tests for PPH. Finally, the reviewed 
literature spans a 30 year time period (1984–2015), which has seen dramatic changes in 
perinatal practice influencing directly the outcome parameters.  
Despite these limitations, this systematic review condenses the existing knowledge on prenatal 
prediction of PPH and need for ECMO, whilst concurrently providing direction for future 
research. It definitively demonstrates the need for larger (collaborative) studies to adjust for 
bias. It also highlights the need for standardized prenatal assessment methods, at standardized 
time points in gestation alongside standardization of postnatal criteria and time points of 
assessment of PPH.  
In conclusion, our meta-analysis demonstrates that ECMO can be reliably predicted by liver 
position and lung size, but we failed to identify a reliable predictor of PPH.  
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Table 1: Proposed predictors for PPH  
Index test Technique Number of studies Consistency among studies 
LHR US 6  No 
o/e LHR US 5  No 
Lung/thorax ratio US 2  No 
o/e contralateral lung area US 1  / 
TLV/FBW US 2  No 
TLV MR 1   
o/e TLV US/MR 4  No 
Pulmonary artery PI US 1  / 
Pulmonary artery ΔPI after 
hyperoxygenation 
US 1  / 
Pulmonary artery AT/ET US 1  / 
Vascularization index US 2  Yes: associated 
Flow index US 1  / 
Quantitative lung index US 1  / 
o/e Pulmonary artery 
diameter 
US 2  Yes: associated 
McGoon index MR 1  / 
Prenatal pulmonary 
hypertension index 
MR 1  / 
Liver herniation US/MR 5 No 
Liver/Thorax ratio US 1  / 
Stomach position US 1  / 
Nuchal translucency  US 1  / 
Side US 2  Yes: not associated 
GA at diagnosis N.A. 1  / 
GA at delivery N.A. 2  No 
Interval balloon removal-
delivery 
N.A. 1  / 
LHR: lung-to-head ratio; o/e: observed/expected; TLV: total lung volume; FBV: fetal body 
volume; PI: pulsatility index; AT/ET: acceleration time/ejection time; GA: gestational age; 
US: ultrasound; MR: magnetic resonance; N.A.: not applicable.  
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Table 2: Proposed predictors for need for ECMO 
Index test Technique Number of studies Consistency among studies 
LHR US 11  No 
o/e LHR US 5 No 
Lung/thorax ratio US 1 / 
TLV MR 2 No 
TLV/FBV MR 1 / 
TLV growth rate MR 1 / 
o/e TLV MR 5 No 
o/e contralateral TLV MR 1 / 
PPLV MR 1 / 
Liver herniation US/MR 10 No 
% liver herniation MR 1 / 
Liver/thorax ratio MR 1 / 
Stomach position US/MR 3 No 
Bowel position MR 1 / 
Side N.A. 3 Yes: not associated 
GA at diagnosis N.A. 2 No 
GA at delivery N.A. 4 No 
Birthweight N.A. 2 No 
LHR: lung-to-head ratio; o/e: observed/expected; TLV: total lung volume; FBV: fetal body 
volume; PPLV: percent predicted lung volume; GA: gestational age; US: ultrasound; MR: 
magnetic resonance; N.A.: not applicable.  
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